Volume 10 — November 14, 2013
Obesity, Mortality, and Life Years Lost Associated With Breast Cancer in Nonsmoking US Women, National Health Interview Survey, 1997–2000
Su-Hsin Chang, PhD; Lisa M. Pollack, MPT, MPH; Graham A. Colditz, MD, DrPH
Suggested citation for this article: Chang S, Pollack LM, Colditz GA. Obesity, Mortality, and Life Years Lost Associated With Breast Cancer in Nonsmoking US Women, National Health Interview Survey, 1997–2000. Prev Chronic Dis 2013;10:130112. DOI: http://dx.doi.org/10.5888/pcd10.130112.
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Preventing Chronic Disease. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/pcd; (4) view/print certificate.
Release date: November 13, 2013; Expiration date: November 13, 2014
Upon completion of this activity, participants will be able to:
AUTHORS AND CREDENTIALS
The relationship between obesity and breast cancer has been extensively investigated. However, how obesity and breast cancer interplay to affect mortality and life expectancy of women in the United States has not been well studied.
We used data from the National Health Interview Survey, 1997–2000. Our sample included nonsmoking, nonpregnant women who reported a body mass index of at least 18.5 kg/m2 and no cancer other than breast cancer at the time of the survey. A survival model with Gamma frailty and Gompertz baseline was used to estimate relative risks of total mortality and project life years lost associated with breast cancer by obesity status and age.
Breast cancer increased risk of mortality depending on degree of obesity and decreased life years by 1 to 12 years depending on race, age, and obesity status. Relative risks for death increased with degree of obesity. Obese women under age 50 across all racial groups were predicted to lose the most life years; racial groups other than whites and blacks lost the most life years (11.9 y), followed by whites (9.8 y) and blacks (9.2 y).
The number of life years lost associated with breast cancer was more marked for more obese than for less obese women and for women under age 50 and women aged 70 or older than for women aged 50 through 69. Public health initiatives should put more emphasis on the prevention and control of obesity for these target populations.
Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of death among women (1). Obesity is a known risk factor for postmenopausal breast cancer (2,3) but may be inversely related to premenopausal breast cancer incidence (4). Obesity is also associated with increased all-cause mortality (5–7). However, it is unclear how obesity and breast cancer interplay to affect mortality and life expectancy of adult women. Some studies have focused on obesity in relation to breast cancer incidence (8–10); others have explored the relationship between obesity and mortality from breast cancer (11–13). Few studies have examined life expectancy associated with breast cancer (14,15). To our knowledge, no studies have considered this association in relation to body mass index (BMI). Our study is the first to consider BMI in the relationship between breast cancer and mortality rate as well as life years lost associated with breast cancer. Our study used both life years lost and mortality rate, which are accepted outcome measures of population health (16,17).
The goal of this study is to investigate the mortality risks associated with breast cancer according to BMI level and race and to predict life years lost among women in the United States. We used data from a national probability sample of the US population and a class of survival model. The projection of life years is computed on the basis of mortality estimates and the observed characteristics of the sample as a snapshot of their life span. This approach is not restricted by the length of mortality follow-up and the observed mortality rates, and thus provides an alternative to the life table approach (14).
Data and the sample
Data from the National Health Interview Survey (NHIS) and the NHIS Linked Mortality Public-Use Files were used in this study (18). The NHIS is a cross-sectional household interview survey providing health information on the civilian, noninstitutionalized household population of the United States. The NHIS consists of 3 major components: Family, Sample Adult, and Sample Child. From each family, 1 sample adult (aged 18 years or older) and 1 sample child (if any children under age 18 are present) are randomly selected, and information on each is collected from the sample adult core and the sample child core questionnaires. The Sample Adult Data Files from 1997 to 2000 were used and linked to the data in the NHIS Linked Mortality Public-Use Files by personal identification numbers. Mortality data followed up the NHIS sample from the date of interview through December 31, 2006.
We focused on female breast cancer; therefore, our sample included only women. The sample exclusion criteria were the following: 1) women with any missing data; 2) women who had smoked more than 100 cigarettes in their entire life, because analyses can be confounded by illnesses associated with smoking (6,7); 3) women pregnant at the time of survey, because BMI levels are unstable during pregnancy; 4) women who reported having had any type of cancer other than breast cancer, to exclude the possibility of breast cancer as a secondary cancer; and 5) underweight women, because disease-driven weight loss could perplex the analysis.
Outcome variable and covariates
The outcome variable was age at death or censor (December 31, 2006). We controlled for breast cancer, BMI (self-reported), race, age at the time of survey, alcohol consumption, physical activity, and educational attainment. Breast cancer information included breast cancer status and the duration from the time of diagnosis to that of the survey. For women with no breast cancer diagnosis reported, the duration was recorded as zero. BMI classifications were based on the standards established by the World Health Organization (19): overweight, BMI 25.0–29.9 kg/m2; class I obese, BMI 30.0–34.9 kg/m2; class II obese, BMI 35.0–39.9 kg/m2; and class III obese, BMI 40 kg/m2 or higher. Normal-weight women (BMI 18.5–24.9 kg/m2) were the reference group. Age at survey was described using 5 age categories: 30 to 39, 40 to 49, 50 to 59, 60 to 69, and 70 years or older. Age 30 or under was the reference category. For race, dichotomized variables for whites and blacks were used. Racial groups other than whites and blacks were the reference group. Interaction terms of breast cancer status with BMI, age, and racial groups were included as covariates.
The additional covariates were dichotomized as follows: educational attainment (whether a person was a high school graduate); alcohol consumption (whether a person had had no more than 12 drinks of any type of alcoholic beverage in the person’s entire life at time of survey); and physical activity (whether a person engaged in light/modest or vigorous physical activity for at least 10 minutes more than once per week).
A survival model with Gamma frailty and Gompertz baseline was used (20). Maximum pseudo-likelihood estimation was performed to adjust for complex sampling design in the NHIS data (21). The estimates were used to compute hazard ratios for death (relative risks, RRs) (22) by BMI and racial groups for people with breast cancer and without any cancer. Life years were predicted by a closed-form expression (23). The sample was divided into subsamples with different combinations of race (whites, blacks, and other), age (aged <50 y, 50–69 y, and ≥70 y), and obesity status (obese: class I–III; nonobese: normal weight and overweight). For each subsample, a sample was selected on the basis of sampling weights, and life years were predicted on the basis of characteristics of the subsample. Within the same subsample, the number of life years lost was projected by comparing the predicted life years of women with breast cancer to the predicted life years of the same women had they not had breast cancer. The bootstrap method was performed to resample the subpopulations 1,000 times to compute the means and standard errors (24).
All estimations and bootstraps were adjusted for the complex sampling design in the NHIS (25). Stata version 11 (Stata Corp LP, College Station, Texas) was used to obtain the summary statistics for the sample and the population, and Matlab version 7.13, R2012b (MathWorks Inc, Natick, Massachusetts) was used to perform estimations and predictions.
The initial sample size of women in our data was 70,651. The remaining sample after applying the exclusion criteria consisted of 35,853 women, representing a US population estimated at 51,860,143 (95% confidence interval [CI], 50,944,982–52,775,304) nonsmoking adult women (aged ≥18 y) (Figure 1). Of the population, 78% were white and 14% were black (Table 1). The average BMI was 26.3 kg/m2 (Table 2); 50% of the population had normal weight; 28% had a BMI within the overweight range; 14% belonged to class I obese; 5% belonged to class II obese; and 3% fell into class III obese (Table 1).
Figure. Data attrition diagram, study on obesity, mortality, and life years lost associated with breast cancer in nonsmoking US women, National Health Interview Survey (NHIS), 1997–2000. [A text description of this figure is also available.]
A total of 771 women in the sample (representing an estimated population of 1,058,767 [95% CI, 972,625–1,144,909]) reported having had a breast cancer diagnosis before the survey. The mean time from their cancer diagnosis to the time of survey was 9.8 years (95% CI, 9.0–10.6) for the population (Table 2). The mean age of the population was 45 years (95% CI, 44.7–45.3). Breast cancer survivors were older on average (66.8 y; 95% CI, 65.6–67.9) than women who did not report any cancer (44.6 y; 95% CI, 44.3–44.9). By 2006, a total of 3,104,152 (95% CI, 2,947,591–3,260,714) all-cause deaths were estimated in this population (260,108 deaths for breast cancer survivors and 2,844,044 deaths for women without any cancer). The mean age at death was estimated at 78.4 (95% CI, 76.5–80.4) for breast cancer patients and 77.9 (95% CI, 77.2–78.6) for women without any cancer in the population.
We analyzed the adjusted relative risks of total mortality for women with breast cancer and without any cancer at survey by BMI group. In the presence of breast cancer, relative risks increased with degree of obesity: 1.63 (95% CI, 1.28–2.07) for the class I obese, 2.66 (95% CI, 2.16–3.29) for the class II obese, and 8.49 (95% CI, 6.20–11.64) for the class III obese. However, overweight women did not appear to be at an increased risk of mortality (RR, 0.90; 95% CI, 0.71–1.13). In the absence of any cancer, any degree of obesity increased mortality risk: 1.10 (95% CI, 1.07–1.13) for overweight, 1.18 (95% CI, 1.14–1.21) for the class I obese, 1.90 (95% CI, 1.81–1.99) for the class II obese, and 2.88 (95% CI, 2.72–3.06) for the class III obese.
The risk of mortality was higher for black women (RR, 1.29; 95% CI, 1.21–1.36) than for white women (RR, 0.88; 95% CI, 0.83–0.93) when cancer was not reported. When breast cancer was reported, relative risks were 1.03 (95% CI, 0.82–1.30) for whites and 1.59 (95% CI, 1.29–1.95) for blacks, compared with racial groups other than blacks and whites. It should be noted that some regression coefficients were not significant, possibly because of multicollinearity resulting from adding interaction terms (26). However, the overall model fit was significant (F = 117.11, P value < .001).
Across all ages, obese (class I–III obese) women with breast cancer lost more life years than their nonobese (normal-weight and overweight) counterparts. Obese whites lost 4.7 (95% CI, 4.1–5.3) life years; obese blacks lost 4.7 (95% CI, 3.0–6.4) years; and obese racial groups other than whites and blacks lost approximately 5.1 (95% CI, 2.9–7.4) life years. Nonobese breast cancer patients lost fewer life years than their obese counterparts: 3.5 (95% CI, 3.1–3.9) years for whites, 3.5 (95% CI, 2.2–4.8) years for blacks, and 4.0 (95% CI, 2.6–5.4) years for all other racial groups.
If breast cancer was present in obese women aged 50 or less, life years lost were 9.8 years (95% CI, 7.6–12.0) for whites, 9.2 (95% CI, 6.4–12.0) for blacks, and 11.9 (95% CI, 5.7–18.0) for all other racial groups. Fewer life years were lost for nonobese women aged 50 or less: 7.9 years (95% CI, 6.7–9.0) for whites, 5.3 (95% CI, 3.0–7.7) for blacks, and 6.0 (95% CI, 5.7–6.2) years for all other racial groups (Table 3). Obese women aged 50 through 69 lost more life years associated with breast cancer than nonobese women of the same age: 3.8 years (95% CI, 3.0–4.7) for obese whites, compared with 1.3 (95% CI, 0.6–2.0) for nonobese whites; 2.5 (95% CI, 0.97–4.1) for obese blacks, compared with 0.6 (95% CI, −1.4−2.6) for nonobese blacks; and 3.8 (95% CI, 2.3−5.2) for obese members of other racial groups compared with 1.7 (95% CI, −0.2−3.7) for nonobese racial groups other than whites and blacks.
A similar trend was found among women aged 70 or older. For obese women aged 70 or older, the number of life years lost was 4.9 (95% CI, 3.9−5.9) for whites and 6.9 (95% CI, 6.6−7.2) for blacks. With the exception of racial groups other than whites and blacks, the number of life years lost was less for nonobese women aged 70 years or older: 3.7 (95% CI, 3.2−4.2) for whites, 4.5 (95% CI, 3.0−6.0) for blacks, and 5.8 (95% CI, 5.0−7.0) for all other racial groups.
We used the following examples to translate life years lost associated with breast cancer to the proportion of total life years. An obese white woman under age 50 with breast cancer was expected to lose 9.8 years of life, which translates to a 12.1% reduction in the expected total life years (81.4 years) for a white woman aged 40 years (27). Similarly, an obese black woman under age 50 with breast cancer was expected to lose 9.2 years of life, which translates to an 11.9% reduction of the total life years (77.5 years) for a black woman aged 40 years (27).
No obvious racial disparity was found in life years lost associated with breast cancer between blacks and whites. Whites (obese and nonobese) lost more life years than their black counterparts for age groups of under 50 and 50 to 69, whereas black women aged 70 years or older lost more life years than white women of the same age range. A plausible explanation is that our data showed fewer breast cancer cases in blacks than in whites and, on average, black women have a higher prevalence of obesity and a shorter life expectancy than white women (1). Therefore, the extent to which breast cancer shortened life years was not as prominent as the extent to which breast cancer increased mortality risk in blacks. Wong et al (28) used a stochastic model to simulate life expectancy for blacks and whites. They found that, of all cancers, breast cancer had the biggest impact on the racial difference in life years lost, accounting for 0.15 years (life years lost for blacks minus that for whites), compared with 0.03 years for obese women and −0.05 years for nonobese women at all ages in our study. The smaller gap between blacks and whites in our study was because the differences were positive and wider for women aged 70 or older (1.94 years for obese women and 0.80 years for nonobese women), whereas the differences were negative for women aged less than 70.
Previous studies that analyzed breast cancer mortality and BMI found results comparable to those of our study: higher mortality among breast cancer patients with a higher degree of obesity. Reeves et al analyzed 1.2 million UK women aged 50 to 64 from 1996 to 2001 and examined mortality from breast cancer in relation to BMI (10). Like us, they found that increasing BMI was associated with a significant increase in the risk of breast cancer mortality. By using data from 1997, Ni Mhurchu et al examined postmenopausal breast cancer mortality in New Zealand and found that higher than optimal BMI (>21 kg/m2) contributed to postmenopausal breast cancer deaths (29); high BMI contributed to 4% of cancer deaths, though the proportion of these deaths that was specific to breast cancer is unknown (29). Our results with regard to mortality rate are consistent with those of Aragón et al, who found that premature mortality attributable to breast cancer among San Francisco residents was the highest among black women compared with other ethnic groups (Asians/Pacific Islanders, Latinos/Hispanics, and whites) (14). However, the predicted life years lost in their study (13.4 years) was generally higher than that in ours, because we focused on nonsmoking women with no other cancer reported at survey and controlled for several confounding variables.
Our study has several strengths. First, our analysis focused on breast cancer and examined its association with mortality and life years, which has not been well studied and deserves more investigation (14,15). Second, the major outcomes of our study are the basic metrics for population health and provide information about mortality and longevity (16). Third, to our knowledge, ours is the first study to incorporate BMI, age, and race information in the analysis of breast cancer, mortality, and life years lost. Fourth, our study advances methodology by controlling for unobserved heterogeneity, allowing for a more precise estimation and prediction of life years lost. This is important for population studies, which lack information specific to breast cancer. Last, we used a national data set, and our conclusions are generalizable to the population of US women.
This study has several limitations, many of which are due to secondary data constraints. First, breast cancer status was dichotomized, preventing us from differentiating the extent of the disease progression or the effects of different types of breast cancers. Second, the data contained few breast cancer cases for women aged less than 40 and for women other than whites and blacks. The predicted life years lost for adult women under 50 and for racial groups other than whites and blacks should be interpreted with this caveat in mind. Third, BMI information was self-reported and recorded only at the time of survey, the latter of which restricted analyses of BMI and mortality at the diagnosis of breast cancer. Fourth, the data used were cross-sectional, and our model is not time-varying and does not capture the dynamics of disease evolution or weight change over time, limiting its projection capability on life years (30,31). Last, our data does not capture menopausal status — shown to differentiate the associations of BMI with breast cancer mortality risk (10) — but this limitation was compensated for by dividing the sample into 3 age groups (<50 y, 50−69 y, and ≥70 y). Future studies should focus on how the extent of breast cancer progression, different types of breast cancers, treatments, or menopausal status affect the prediction of life years lost associated with breast cancer.
Our study suggests that breast cancer increased the risk of early mortality depending on degree of obesity and decreased life years by 1 to 12 years depending on race, age, and obesity status. The number of life years lost associated with breast cancer was higher for more obese women aged less than 50 than for nonobese women of the same age. Moreover, obese women with breast cancer aged less than 50 and older than 70 bear a higher burden in terms of years of life lost. Public health initiatives should put more emphasis on the prevention and control of obesity for these target populations.
Funding for this study was provided from the KM1CA156708–01 through the National Cancer Institute at the National Institutes of Health, grant no. U54 CA 155496, and Barnes-Jewish Hospital Foundation. Dr Colditz is supported by an American Cancer Society Clinical Research Professorship.
Corresponding Author: Su-Hsin Chang, PhD, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8100, St Louis, MO 63110. Telephone: 314-362-8623. E-mail: email@example.com.
Author Affiliations: Lisa M. Pollack, George Warren Brown School of Social Work, Washington University in St Louis, St Louis, Missouri; Graham A. Colditz, Washington University School of Medicine, St Louis, Missouri.
- American Cancer Society. Cancer facts and figures 2012. Atlanta (GA): American Cancer Society; 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc–031941.pdf. Accessed March 15, 2013.
- Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95(16):1218–26. CrossRef PubMed
- Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5(3):153–65. CrossRef PubMed
- Baer HJ, Colditz GA, Rosner B, Michels KB, Rich-Edwards JW, Hunter DJ, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 2005;7(3):R314–25. CrossRef PubMed
- Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293(15):1861–7. CrossRef PubMed
- Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341(15):1097–105. CrossRef PubMed
- Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363(23):2211–9. Erratum in N Engl J Med 2011;365(9):869. CrossRef PubMed
- Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor–positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20(3):454–63. CrossRef PubMed
- Pujol P, Galtier-Dereure F, Bringer J. Obesity and breast cancer risk. Hum Reprod 1997;12(Suppl 1):116–25. CrossRef PubMed
- Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335(7630):1134. CrossRef PubMed
- Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298(17):2028–37. CrossRef PubMed
- Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010;123(3):627–35. CrossRef PubMed
- Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J, et al. Is body mass index the prognostic factor in breast cancer?: a meta-analysis. J Korean Med Sci 2001;16(5):610–4. PubMed
- Aragón TJ, Lichtensztajn DY, Katcher BS, Reiter R, Katz MH. Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health 2008;8:116. CrossRef PubMed
- Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden –– and should be considered when allocating research funds. Br J Cancer 2005;92(2):241–5. PubMed
- Parrish RG. Measuring population health outcomes. Prev Chronic Dis 2010;7(4):A71. PubMed
- Pronk NP, Hernandez LM, Lawrence RS. An integrated framework for assessing the value of community-based prevention: a report of the Institute of Medicine. Prev Chronic Dis 2013;10:120323. CrossRef PubMed
- Centers for Disease Control and Prevention. National Health Interview Survey (NHIS) public-use linked mortality files: survey years 1986–2004. 2010. http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhis_linkage.htm. Accessed November 15, 2011.
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1–253. PubMed
- Vaupel JW, Manton KG, Stallard E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 1979;16(3):439–54. CrossRef PubMed
- Sakata S. Quasi-maximum likelihood estimation with complex survey data. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.27.212&rep=rep1&type=pdf. Mimeo 2002. Accessed April 9, 2012.
- Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. 2nd edition. New York (NY): Springer; 2003. xv, 536.
- Missov TI. Gamma–Gompertz life expectancy at birth. Demogr Res 2013;28:259–70. CrossRef
- Rao JNK, Wu CFJ. Resampling inference with complex survey data. J Am Stat Assoc 1988;83(401):231–41. CrossRef
- Botman SL, Moore TF, Moriarity CL, Parsons VL. Design and estimation for the National Health Interview Survey, 1995−2004. Vital Health Stat 2 ;(130):1–31. http://www.cdc.gov/nchs/data/series/sr_02/sr02_130.pdf. Accessed February 19, 2012. PubMed
- Wooldridge JM. Introductory econometrics: a modern approach. 4th edition. Mason (OH): South Western, Cengage Learning; 2009. p. 241–2.
- Anderson RN. United States life tables, 1998. Natl Vital Stat Rep 2001;48(18):1–40. CrossRef PubMed
- Wong MD, Ettner SL, Boscardin WJ, Shapiro MF. The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy. J Gen Intern Med 2009;24(4):475–81. CrossRef PubMed
- Ni Mhurchu C, Turley M, Stefanogiannis N, Lawes CM, Rodgers A, Vander Hoorn S, et al. Mortality attributable to higher–than–optimal body mass index in New Zealand. Public Health Nutr 2005;8(4):402–8. CrossRef PubMed
- Chang SH, Stoll CR, Colditz GA. Cost–effectiveness of bariatric surgery: should it be universally available? Maturitas 2011;69(3):230–8. CrossRef PubMed
- Chang SH, Pollack LM, Colditz GA. Life years lost associated with obesity-related diseases for US non-smoking adults. PLoS ONE 2013;8(6):e66550. CrossRef PubMed
Table 1. Descriptive Statistics for Nonsmoking US Women in the Sample and the Population From the National Health Interview Survey, 1997–2000a
|Variable||Breast Cancer||No Cancer||Total|
|n||N (SE)||n||N (SE)||n||N (SE)|
|Total||771||1,058,767 (43,768)||35,082||50,801,376 (459,460)||35,853||51,860,143 (465,260)|
|All-cause death||208||260,108 (20,253)||2,438||2,844,044 (76,011)||2,646||3,104,152 (795,920)|
|White||661||924,138 (41,498)||25,941||39,459,691 (389,888)||26,602||40,383,829 (394,164)|
|Black||76||84,151 (9,755)||6,060||7,219,083 (202,540)||6,136||7,303,234 (205,566)|
|Other||34||50,478 (109,29)||3,081||4,122,602 (128,190)||3,115||41,73,080 (128,575)|
|Normal weight||315||433,178 (26,915)||16,859||25,531,527 (289,971)||17,174||25,964,705 (291,154)|
|Overweight||269||379,179 (28,156)||10,235||14,356,072 (196,833)||10,504||14,735,251 (201,082)|
|Class I obese||136||175,026 (16,906)||5,043||6,881,706 (124,430)||5,179||7,056,731 (125,298)|
|Class II obese||34||53,465 (9,871)||1,800||2,471,069 (73,607)||1,834||2,524,534 (73,495)|
|Class III obese||17||17,920 (4,738)||1,145||1,561,003 (57,872)||1,162||1,578,922 (58,002)|
|Age group, y|
|<30||7||11,715 (5,337)||7,664||12,188,840 (207,881)||7,671||12,200,555 (208,345)|
|30–39||19||26,668 (6,681)||7,850||10,964,477 (160,630)||7,869||10,991,145 (160,655)|
|40–49||65||100,383 (14,445)||6,437||10,061,258 (176,813)||6,502||10,161,641 (177,674)|
|50–59||113||168,871 (19,351)||4,248||6,461,688 (122,378)||4,361||6,630,559 (123,705)|
|60–69||153||221,380 (18,495)||3,342||4,567,730 (99,367)||3,495||4,789,110 (103,801)|
|≥70||414||529,750 (28,844)||5,541||6,557,384 (129,219)||5,955||7,087,134 (136,195)|
|≥ High school graduate||585||821,615 (38,200)||27,156||41,660,054 (412,085)||27,741||42,481,669 (417,161)|
|< High school graduate||186||237,152 (20,158)||7,926||9,141,323 (174,170)||8,112||9,378,475 (174,589)|
|≤12 drinks||143||190,923 (17,843)||4,245||5,928,126 (118,714)||4,388||6,119,050 (119,701)|
|>12 drinks||628||867,844 (40,341)||30,837||44,873,250 (427,473)||31,465||45,741,094 (433,428)|
|Yes||303||451,699 (29,693)||16,760||26,152,738 (318,522)||17,063||26,604,438 (321,812)|
|No||468||607,068 (31,665)||18,322||24,648,638 (277,708)||18,790||25,255,706 (279,927)|
Table 2. Continuous Variables for Nonsmoking US Women From the National Health Interview Survey, 1997–2000
|Variable||Breast Cancer||No Cancer||Total|
|Sample Mean||Population Mean (SE)||Sample Mean||Population Mean (SE)||Sample Mean||Population Mean (SE)|
|BMI, kg/m2||26.9||26.8 (0.18)||26.6||26.3 (0.04)||26.6||26.3 (0.04)|
|Duration from breast cancer diagnosis to survey, y||7.7||9.8 (0.42)||0.0||0.0||7.7||9.8 (0.42)|
|Mortality follow-up, y||6.7||8.5 (0.04)||7.3||8.5 (0.01)||7.3||8.5 (0.01)|
|Age at survey, y||67.8||66.8 (0.59)||46.8||44.6 (0.15)||47.3||45.0 (0.16)|
|Age at death, y||79.5||78.4 (0.97)||79.1||77.9 (0.35)||79.1||77.9 (0.33)|
Table 3. Predicted Life Years Lost Associated With Breast Cancer for Nonsmoking US Women by Obesity Status, Age, and Race, National Health Interview Survey, 1997–2000a
|Obesity Status||Age, y||White, y (SE)||Black, y (SE)||Other, y (SE)|
|Obese||All||4.66 (0.31)||4.69 (0.85)||5.12 (1.16)|
|<50||9.77 (1.13)||9.22 (1.42)||11.85 (3.12)|
|50–69||3.84 (0.41)||2.52 (0.79)||3.75 (0.72)|
|≥70||4.93 (0.51)||6.87 (0.15)||5.17 (0)|
|Nonobese||All||3.53 (0.21)||3.48 (0.65)||3.97 (0.71)|
|<50||7.85 (0.61)||5.32 (1.22)||5.97 (0.13)|
|50–69||1.31 (0.35)||0.62 (1.02)||1.74 (0.99)|
|≥70||3.68 (0.25)||4.48 (0.78)||5.81 (0.62)|
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn continuing medical education (CME) credit, please go to http://www.medscape.org/journal/pcd. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the “Register” link on the right hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to http://www.ama-assn.org/ama/pub/about-ama/awards/ama-physicians-recognition-award.page. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the AMA PRA CME credit certificate and present it to your national medical association for review.
Article Title: Obesity, Mortality, and Life Years Lost Associated With Breast Cancer in Nonsmoking US Women, National Health Interview Survey, 1997-2000
- You are seeing a 48-year-old African American woman with newly diagnosed
breast cancer. She has a history of hyperlipidemia and a body mass index (BMI)
of 36 kg/m2. Based on the current study by Dr. Chang and colleagues,
what can you tell this patient regarding the relationship between obesity and
mortality among women with breast cancer?
- There was no relationship between obesity and the relative risk of mortality
- Only underweight women were at higher risk for mortality
- Only overweight, but not obese, women were at higher risk for mortality
- There was an increasing risk for mortality associated with increasing classes of obesity
- How did the risk of mortality associated with obesity compare among women
with and without breast cancer?
- Obesity was associated with a higher risk of mortality only among women with breast cancer
- Obesity was associated with a higher risk of mortality only among women without breast cancer
- Obesity increased the risk of death to a greater degree among women with breast cancer compared with those without breast cancer
- Obesity increased the risk of death to a greater degree among women without breast cancer compared with those with breast cancer
- According to the current study, what role does this patient’s age play in the
relationship between obesity and her risk of mortality?
- Obesity was only associated with early mortality among women under 50 years old
- Obesity was associated with the greatest number of life years lost among women under 50 years old
- Obesity was only associated with early mortality among women aged 70 years or older
- Obesity was associated with the greatest number of life years lost among women aged 70 years or older
- According to the current study, what role does this patient’s race/ethnicity
play in the relationship between obesity and her risk of mortality?
- Obesity resulted in a greater number of life years lost among black women vs white women
- Obesity resulted in a greater number of life years lost among other racial/ethnic groups compared with black and white women
- Obesity only increased the risk of mortality among black women
- Race/ethnicity did not affect the risk of mortality associated with obesity
|1. The activity supported the learning objectives.|
|Strongly Disagree||Strongly Agree|
|2. The material was organized clearly for learning to occur.|
|Strongly Disagree||Strongly Agree|
|3. The content learned from this activity will impact my practice.|
|Strongly Disagree||Strongly Agree|
|4. The activity was presented objectively and free of commercial bias.|
|Strongly Disagree||Strongly Agree|
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.